[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100572476":3},{"organization":4,"outcomesModule":7,"designInfo":32,"detailedDescription":35,"studyPopulation":36,"armGroups":37,"interventions":42,"overallOfficials":47,"centralContacts":51,"locations":58,"responsibleParty":75,"collaborators":31,"id":78,"slug":31,"hasResults":79,"nctId":80,"briefTitle":81,"officialTitle":82,"acronym":31,"eligibilityCriteria":83,"healthyVolunteers":79,"sex":84,"minAge":85,"maxAge":31,"enrollmentInfo":86,"targetDuration":31,"studyType":89,"phases":31,"briefSummary":90,"conditions":91,"keywords":31,"overallStatus":60,"whyStopped":31,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"Chinese PLA General Hospital","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":31},[9],{"measure":10,"description":11,"timeFrame":12},"rate of disease progression","cervical lymph node metastases and persistent tumors confirmed by pathology, Distant metastasis detected by CT, positron emission tomography, or bone scan if there were suspicious symptoms.","through study completion, an average of 6 months",[14,18,21,24,27],{"measure":15,"description":16,"timeFrame":17},"rate of complications","complication of ablation","1 week",{"measure":19,"description":20,"timeFrame":12},"rate of volume reduction","volume reduction of tumor after ablation on ultrasound and contrast-enhanced ultrasound",{"measure":22,"description":23,"timeFrame":12},"rate of tumor disappearance","complete disappearance of ablated tumor on ultrasound and contrast-enhanced ultrasound",{"measure":25,"description":26,"timeFrame":12},"Tg level","serum thyroglobulin level",{"measure":28,"description":29,"timeFrame":30},"rate of delayed surgery","patients underwent surgery after ablation because of anxiety","through study completion, an average of 1 year",null,{"allocation":31,"interventionModel":31,"interventionModelDescription":31,"primaryPurpose":31,"observationalModel":33,"timePerspective":34,"maskingInfo":31},"COHORT","PROSPECTIVE","To evaluate and predict the long-term outcomes of ultrasound-guided thermal ablation for recurrent thyroid cancer by a multicenter study","patients with recurrent thyroid cancer",[38],{"label":39,"type":31,"description":39,"interventionNames":40},"ultrasound-guided thermal ablation",[41],"Procedure: ultrasound-guided thermal ablation",[43],{"type":44,"name":39,"description":45,"armGroupLabels":46,"otherNames":31},"PROCEDURE","microwave ablation, radiofrequency ablation, laser ablation",[39],[48],{"name":49,"affiliation":5,"role":50},"Yukun Luo","PRINCIPAL_INVESTIGATOR",[52],{"name":53,"role":54,"phone":55,"phoneExt":56,"email":57},"Lin Yan","CONTACT","13811237313","86","gemma-y@163.com",[59],{"facility":5,"status":60,"city":61,"state":62,"zip":63,"country":64,"countryCode":65,"cosmosGeoPoint":66,"geoPoint":71,"contacts":72},"RECRUITING","Beijing","Beijing Municipality","100853","China","CN",{"type":67,"coordinates":68},"Point",[69,70],116.39723,39.9075,{"lat":70,"lon":69},[73,74],{"name":53,"role":54,"phone":31,"phoneExt":31,"email":31},{"name":53,"role":50,"phone":31,"phoneExt":31,"email":31},{"type":50,"investigatorFullName":76,"investigatorTitle":77,"investigatorAffiliation":5,"oldNameTitle":31,"oldOrganization":31},"Yu-kun Luo","Clinical Professor","100572476",false,"NCT06733766","Ultrasound-guided Thermal Ablation for Recurrent Thyroid Cancer","Ultrasound-guided Thermal Ablation for Recurrent Thyroid Cancer: A Multicenter Study","Inclusion Criteria:\n\n1. patient received thyroidectomy for thyroid cancer\n2. recurrent lesions were pathologically proven to be malignant by core-needle biopsy or fine needle aspiration\n3. no evidence of distant metastases.\n4. follow-up period ≥12 months\n\nExclusion Criteria:\n\n1. coagulation disorder, serious heart, respiratory, liver, or renal failure\n2. dysfunction of the vocal cord on the opposite side","ALL","18 Years",{"count":87,"type":88},300,"ESTIMATED","OBSERVATIONAL","To evaluate the long-term outcomes of ultrasound-guided thermal ablation for recurrent thyroid cancer",[92],"Recurrent Thyroid Cancer","2025-02-13",{"date":95,"type":96},"2025-02-14","ACTUAL",{"date":98,"type":96},"2024-12-09",{"date":100,"type":88},"2030-12-31",{"name":5,"class":6},1]